Latest News

CMS Proposes to Spin-off and Separately List the Shares of Dermavon on the Main Board of HKEX
2025-04-22

CMS Proposes to Spin-off and Separately List the Shares of Dermavon on the Main Board of HKEX

The Company proposes to spin-off and separately list the shares of Dermavon, a subsidiary of the Company, on the Main Board of the Stock Exchange. The Proposed Spin-off, if proceeded, is expected to be implemented through a distribution in specie by the Company of all the shares in Dermavon that it holds to the Shareholders in proportion to their respective shareholding in the Company as of a record date to be determined by the Board for the purpose of ascertaining the Shareholders’ entitlements. The separate listing of the shares of Dermavon on the Stock Exchange constitutes a spin-off of Dermavon by the Company under the Practice Note 15 to the Listing Rules. The Stock Exchange has confirmed that the Company may proceed with the Proposed Spin-off. In connection with the Proposed Spin-off, on 22 April 2025, Dermavon submitted an application to the Stock Exchange for the listing of, and permission […]

Learn More
China Medical System has been Included in the S&P Global Sustainability Yearbook (China Edition) for the 3rd Consecutive Year
2025-04-15

China Medical System has been Included in the S&P Global Sustainability Yearbook (China Edition) for the 3rd Consecutive Year

On April 15, 2025, S&P Global officially released the Sustainability Yearbook (China Edition) 2025. China Medical System Holdings Limited (“CMS” or the “Group”) has stood out among over 1,600 Chinese companies with its outstanding performance in environmental, social, and governance (ESG) practices, marking its third consecutive year of inclusion in the Yearbook. Source: S&P Global   CMS has been implementing the concept of sustainable development into its strategy formulation and daily operation, focusing on unmet healthcare needs to provide better treatment solutions for doctors and patients, and striving to improve the accessibility and affordability of pharmaceutical products. At the same time, the Group has been continuously optimizing its internal governance, upholding the bottom line of product responsibility, respecting and empowering employees, and actively participating in public welfare, charity, and environmental protection activities, thus promoting a virtuous cycle of corporate development and responsibility fulfillment.   Through persistent dedication to sustainable development, […]

Learn More
Restructuring and Breakthroughs: “New CMS” Starts a “New Journey” of Innovation丨CMS(867.HK)2024 Annual Performance Report in One Picture
2025-03-17

Restructuring and Breakthroughs: “New CMS” Starts a “New Journey” of Innovation丨CMS(867.HK)2024 Annual Performance Report in One Picture

Learn More

The news on this page is intended to share cutting-edge medical information and is for academic reference only by medical and health professionals, not for advertising purposes. CMS does not recommend any drugs, medical devices and/or indications. The news information on this page is for reference only. Please follow the advice or guidance of your doctor or other healthcare professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. If you have understood and confirmed the above content, please click OK to enter.

All News